Currently, the 750mcg teriparatide injection product is obtainable in Australia but its supply is conditional. Generally, it’s prescribed for patients with debilitating osteoporosis who exhibit an lack to respond adequately to, or cannot tolerate, other therapies. The cost can fluctuate significa